SONOMA PHARMACEUTICALS, INC. (SNOA) Operating margin 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) operating margin by fiscal year — reported operating income divided by reported revenue.
-12.6%FY2026 · since FY2017: -101.2% → -12.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -12.6% | +13.4 pp |
| FY2025 | -26.0% | +10.9 pp |
| FY2024 | -36.9% | -2.5 pp |
| FY2023 | -34.4% | +12.2 pp |
| FY2022 | -46.6% | -28.1 pp |
| FY2021 | -18.5% | +22.7 pp |
| FY2020 | -41.2% | +18.1 pp |
| FY2019 | -59.3% | +25.8 pp |
| FY2018 | -85.2% | +16.0 pp |
| FY2017 | -101.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice